Aleksandar Kovacevic vs Alan Magadan Prediction & Picks - ATP Acapulco Open
ATP - ATP Acapulco Open
Prediction:
Aleksandar Kovacevic will win 2-0
New customers only | Commercial content | 21+ age limit | T&Cs apply
by Lou Aguila | in Tennis Picks
Aleksandar Kovacevic of the United States hopes to replicate his run in Montpellier with another deep campaign at the 2025 Acapulco Open. He’s set to begin his quest against Alan Magadan of Mexico on Saturday. After winning the Oeiras Challenger in January, Kovacevic carried his terrific form into the Open Occitanie in Montpellier, where he went on a giant-slaying run, eliminating established names such as David Goffin, Pablo Carreno-Busta, Matteo Bellucci, Alexander Bublik and Andrey Rublev. He fell short of capturing the title after running out of steam in the final against Felix Auger-Aliassime 6-2 6-7(7) 7-6(2), but that amazing run put everyone on the tour on notice about his caliber as a player. Magadan is fresh off a solid run at M25 Ithaca, reaching the quarterfinal stages where he lost to Alex Rybakov of the United States 7-6(5) 6-2. The 23-year-old Magadan hasn’t played in any Grand Slam or Masters 1000 event yet, so there’s only little information available about him.
Aleksandar Kovacevic - Alan Magadan Key Points
- Aleksandar Kovacevic reached the final of the 2025 Open Occitanie
- Aleksandar Kovacevic ranks No.77 in the world.
- Alan Magadan ranks No.890 in the world.
- Alan Magadan hasn’t played in a Grand Slam event.
Our Aleksandar Kovacevic vs Alan Magadan Prediction
There’s no way Aleksandar Kovacevic will lose this match. Unless a freak injury happens during the match, Kovacevic is bound for an emphatic straight-set win over Magadan, who is a regular campaigner outside the Main ATP Tour in ITF/Challenger tournaments. Kovacevic is a legit top-100 player with a skill that can compete with top-20, top-10 players. Our betting prediction for Aleksandar Kovacevic vs. Alan Magadan: Kovacevic will win 2-0.
Prediction:
Aleksandar Kovacevic will win 2-0
All tips are fully researched and given in good faith, but profits cannot be guaranteed.